[Changes of erythrocyte deformability induced by calcium accumulation and calmodulin inhibitors].
The deformability of human erythrocytes was investigated with a rheoscope to study the role of intracellular calcium in the dynamic cytoskeletal structure. Calcium was loaded to or depleted from erythrocytes with a calcium ionophore (A 23187) in a Na- or a K-HEPES buffer. (1) After calcium loading in the Na-HEPES buffer, the cell volume of erythrocytes was greatly reduced due to dehydration. On the contrary, upon calcium-loading or -depletion in the K-HEPES buffer, the intracellular calcium content could be varied in the range of 1/4 to 3 times as much as that of control cells without the reduction of mean cell volume. Further incubation without A 23187 and calcium in the K-HEPES buffer enabled the calcium-loaded erythrocytes to restore the cell shape and the ATP concentration. (2) When intracellular calcium content was increased to above 1.5 times of the normal value, the deformability was distinctly decreased. On the other hand, the deformability was unchanged when the intracellular calcium content was reduced below the normal level. (3) The deformability, once decreased due to the calcium accumulation, was recovered by the treatment with a calmodulin inhibitor, W-7 or trifluoperazine, while these drugs were not effective on the deformability of control or calcium-depleted erythrocytes. We conclude that the membrane stiffness which influence the deformability of erythrocytes, is modulated by the intracellular calcium content through the interaction between the calcium-calmodulin complex and the cytoskeletal proteins.
D002118:Calcium / Q000378:metabolism* / Q000502:physiology; D002147:Calmodulin / Q000037:antagonists & inhibitors*; D003598:Cytoskeletal Proteins / Q000097:blood; D004734:Energy Metabolism; D004907:Erythrocyte Deformability / Q000187:drug effects*; D004912:Erythrocytes / Q000378:metabolism; D006801:Humans; D007477:Ions; D011188:Potassium / Q000097:blood; D012964:Sodium / Q000097:blood; D013449:Sulfonamides / Q000494:pharmacology*; D014268:Trifluoperazine / Q000494:pharmacology*
D002147:Calmodulin; D003598:Cytoskeletal Proteins; D007477:Ions; D013449:Sulfonamides; D014268:Trifluoperazine; C017967:W 7; D012964:Sodium; D011188:Potassium; D002118:Calcium